Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 7
Submit an article Journal homepage
145
Views
6
CrossRef citations to date
0
Altmetric
Theme: Arrhythmias & Cardiac Pacing - Review

Quality of life and patient-centered outcomes following atrial fibrillation ablation: short- and long-term perspectives to improving care

Sanghamitra Mohanty St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; School of Biological Sciences, University of Texas at Austin,Austin, TX, USA; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; School of Biological Sciences, University of Texas at Austin,Austin, TX, USA
,
Luigi Di Biase St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Cardiology, University of Foggia, Foggia, Italy; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Cardiology, University of Foggia, Foggia, Italy; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA
,
Rong Bai St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Internal Medicine, Tong-Ji Hospital, Tong-Ji Medical College, Huazhong University of Science and Technology, Wuhan, China; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Internal Medicine, Tong-Ji Hospital, Tong-Ji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Pasquale Santangeli St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Cardiology, University of Foggia, Foggia, Italy; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Cardiology, University of Foggia, Foggia, Italy
,
Agnes Pump St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Faculty of Medicine, Heart Institute, University of Pecs, Pecs, Hungary; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Faculty of Medicine, Heart Institute, University of Pecs, Pecs, Hungary
,
Rodney Horton St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA
,
Javier E Sanchez St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA
&
Andrea Natale St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA; Division of Cardiology, Stanford University, Palo Alto, CA, USA. [email protected]; Interventional Electrophysiology, Scripps Clinic, San Diego, CA, USA; Division of Cardiology, Stanford University, Palo Alto, CA, USA. [email protected]
 show all
Pages 889-900 | Published online: 10 Jan 2014

References

  • Bhargava M, Di Biase L, Mohanty P et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 6(10), 1403–1412 (2009).
  • Ip S, Terasawa T, Balk EM, Chung M, Alsheikh-Ali A, Garlitski AC. Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation. Agency for Healthcare Research and Quality (USA), MD, USA (2009). Report No.: 09-EHC015-EF (2009).
  • Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659–666 (1998).
  • Kazemian P, Oudit G, Jugdutt BI. Atrial fibrillation and heart failure in the elderly. Heart Fail. Rev. 17(4–5), 597–613 (2011).
  • Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271(11), 840–844 (1994).
  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 22(8), 983–988 (1991).
  • Pasquale S, Di Biase L, Mohanty P et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J. Cardiovasc. Electrophysiol. doi:10.1111/j.1540-8167.2012.02293.x. (2012) (Epub ahead of print).
  • Haegeli LM, Duru F, Lockwood EE et al. Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. J. Interv. Card. Electrophysiol. 28(3), 193–197 (2010).
  • Bunch TJ, Weiss JP, Crandall BG et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin. Electrophysiol. 33(2), 146–152 (2010).
  • Tan HW, Wang XH, Shi HF et al. Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians. Int. J. Cardiol. 145(1), 147–148 (2010).
  • Corrado A, Patel D, Riedlbauchova L et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J. Cardiovasc. Electrophysiol. 19(8), 807–811 (2008).
  • Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: ten years later. Gend. Med. 7(3), 206–217 (2010).
  • Watanabe H, Tanabe N, Yagihara N, Watanabe T, Aizawa Y, Kodama M. Association between lipid profile and risk of atrial fibrillation. Circ. J. 75(12), 2767–2774 (2011).
  • Hoyt H, Bhonsale A, Chilukuri K et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm 8(12), 1869–1874 (2011).
  • Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J. Am. Coll. Cardiol. 59(2), 143–149 (2012).
  • Baman TS, Jongnarangsin K, Chugh A et al.. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 22(6), 626–631 (2011).
  • Rostock T, Salukhe TV, Steven D et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm 8(9), 1391–1397 (2011).
  • Patel D, Mohanty P, Di Biase L et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 7(2), 167–172 (2010).
  • Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am. J. Cardiol. 94(7), 889–894 (2004).
  • Potpara TS, Marinkovic JM, Polovina MM et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int. J. Cardiol. doi:10.1016/j.ijcard.2011.04.022 (2011) (Epub ahead of print).
  • Mohanty S, Mohanty P, Di Biase L et al. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation. J. Cardiovasc. Electrophysiol. 22(8), 858–865 (2011).
  • Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448(7151), 353–357 (2007).
  • Liu X, Wang F, Knight AC, Zhao J, Xiao J. Common variants for atrial fibrillation: results from genome-wide association studies. Hum. Genet. 131(1), 33–39 (2011).
  • Viviani Anselmi C, Novelli V, Roncarati R et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart 94(11), 1394–1396 (2008).
  • Kääb S, Darbar D, van Noord C et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur. Heart J. 30(7), 813–819 (2009).
  • Lubitz SA, Sinner MF, Lunetta KL et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 122(10), 976–984 (2010).
  • Gretarsdottir S, Baas AF, Thorleifsson G et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat. Genet. 42(8), 692–697 (2010).
  • Husser D, Adams V, Piorkowski C, Hindricks G, Bollmann A. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J. Am. Coll. Cardiol. 55(8), 747–753 (2010).
  • Wang TJ, Parise H, Levy D et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292(20), 2471–2477 (2004).
  • Tedrow UB, Conen D, Ridker PM et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women’s Health Study). J. Am. Coll. Cardiol. 55(21), 2319–2327 (2010).
  • Ardestani A, Hoffman HJ, Cooper HA. Obesity and outcomes among patients with established atrial fibrillation. Am. J. Cardiol. 106(3), 369–373 (2010).
  • Mohanty S, Mohanty P, Di Biase L et al. Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation. Heart Rhythm 8(12), 1847–1852 (2011).
  • Nguyen JT, Benditt DG. Atrial fibrillation susceptibility in metabolic syndrome: simply the sum of its parts? Circulation 117(10), 1249–1251 (2008).
  • Watanabe H, Tanabe N, Watanabe T et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 117(10), 1255–1260 (2008).
  • Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 159(5), 850–856 (2010).
  • Cai L, Yin Y, Ling Z et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int. J. Cardiol. 10(3), 221–226 (2011).
  • Chang SL, Tuan TC, Tai CT et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am. J. Cardiol. 103(1), 67–72 (2009).
  • Ri-Bo T, Jian-Zeng D, Xing-Peng L et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ. J. 73, 438–443 (2009).
  • Letsas KP, Weber R, Bürkle G et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace 11(2), 158–163 (2009).
  • Mohanty S, Mohanty P, Di Biase L et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J. Am. Coll. Cardiol. 59(14), 1295–1301 (2012).
  • Kipshidze NN, Katsitadze GA, Khosroshvili LB. [Effect of the metabolic syndrome on the electrophysiological parameters of the heart]. Georgian Med. News 119, 9–13 (2005).
  • Oliveira MM, da Silva N, Timóteo AT et al. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation. Rev. Port. Cardiol. 26(7–8), 691–702 (2007).
  • Chilukuri K, Dalal D, Marine JE et al. Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation. Europace 11(7), 896–901 (2009).
  • Tang RB, Dong JZ, Liu XP et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace 11(1), 100–105 (2009).
  • Matiello M, Nadal M, Tamborero D et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 12(8), 1084–1089 (2010).
  • Hoyer FF, Lickfett LM, Mittmann-Braun E et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J. Interv. Card. Electrophysiol. 29(1), 37–41 (2010).
  • Patel D, Mohanty P, Di Biase L et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ. Arrhythm. Electrophysiol. 3(5), 445–451 (2010).
  • Camm JA, Kirchhof P, Lip GYH et al. Guidelines for the management of atrial fibrillation. Eur. Heart J. 31, 2369–2429 (2010).
  • Nilsson B, Chen X, Pehrson S, Køber L, Hilden J, Svendsen JH. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy. Am. Heart J. 152(3), 537.e1–537.e8 (2006).
  • Berruezo A, Tamborero D, Mont L et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur. Heart J. 28(7), 836–841 (2007).
  • Zhuang J, Wang Y, Tang K et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace 14(5), 638–645 (2011)
  • Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24), 2498–2505 (2008).
  • Cha YM, Friedman PA, Asirvatham SJ et al. Catheter ablation for atrial fibrillation in patients with obesity. Circulation 117(20), 2583–2590 (2008).
  • Al Chekakie MO, Akar JG, Wang F et al. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 18(9), 942–946 (2007).
  • Calò L, Lamberti F, Loricchio ML et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. J. Am. Coll. Cardiol. 47(12), 2504–2512 (2006).
  • Chen MS, Marrouche NF, Khaykin Y et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J. Am. Coll. Cardiol. 43(6), 1004–1009 (2004).
  • Hsu LF, Jaïs P, Sanders P et al. Catheter ablation for atrial fibrillation in congestive heart failure. N. Engl. J. Med. 351(23), 2373–2383 (2004).
  • Wilton SB, Fundytus A, Ghali WA et al. Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. Am. J. Cardiol. 106(9), 1284–1291 (2010).
  • Themistoclakis S, Schweikert RA, Saliba WI et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm 5(5), 679–685 (2008).
  • Della Bella P, Riva S, Fassini G et al. Long-term follow-up after radiofrequency catheter ablation of atrial fibrillation: role of the acute procedure outcome and of the clinical presentation. Europace 7(2), 95–103 (2005).
  • Fiala M, Chovancík J, Nevralová R et al. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation. Pacing Clin. Electrophysiol. 31(8), 985–997 (2008).
  • Tao H, Liu X, Dong J et al. Predictors of very late recurrence of atrial fibrillation after circumferential pulmonary vein ablation. Clin. Cardiol. 31(10), 463–468 (2008).
  • Potpara T, Grujic M, Vujisic-Tesic B et al. [Relationship between the type of atrial fibrillation and thromboembolic events]. Vojnosanit. Pregl. 66(11), 887–891 (2009).
  • Hohnloser SH, Pajitnev D, Pogue J et al.; ACTIVE W Investigators. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J. Am. Coll. Cardiol. 50(22), 2156–2161 (2007).
  • Zhou JM, Liu SW, Lin JX et al. Thromboembolic event rate in patients with persistent or paroxysmal atrial fibrillation post circumferential pulmonary vein isolation: a single center experience in China. Chin. Med. J. 120(11), 956–959 (2007).
  • Verma A, Wazni OM, Marrouche NF et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J. Am. Coll. Cardiol. 45(2), 285–292 (2005).
  • Uijl D, Delgado V, Bertini M et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 97, 1847e–1851e (2011).
  • Okumura Y, Watanabe I, Nakai T et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. J. Cardiovasc. Electrophysiol. 22(9), 987–993 (2011).
  • Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J. Am. Coll. Cardiol. 50(21), 2021–2028 (2007).
  • Friedrichs K, Klinke A, Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol. Med. 17(10), 556–563 (2011).
  • Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 13(5), 610–625 (2011).
  • Rahimi K, Emberson J, McGale P et al.; PROSPER Executive. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ 342, d1250 (2011).
  • Ozaydin M. Atrial fibrillation and inflammation. World J. Cardiol. 2(8), 243–250 (2010).
  • Dienera HC, Webera R, Lip G, Hohnloser SH. Stroke prevention in atrial fibrillation: do we still need warfarin? Curr. Opin. Neurol. 25, 27–35 (2012).
  • Calkins H, Brugada J, Packer DL et al.; European Heart Rhythm Association (EHRA) European Cardiac Arrhythmia Scoiety (ECAS) American College of Cardiology (ACC) American Heart Association (AHA) Society of Thoracic Surgeons (STS). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4(6), 816–861 (2007).
  • Yagishita A, Takahashi Y, Takahashi A et al. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation. Circ. J. 75(10), 2343–2349 (2011).
  • Saad EB, d’Avila A, Costa IP et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score =3: a long-term outcome study. Circ. Arrhythm. Electrophysiol. 4(5), 615–621 (2011).
  • Themistoclakis S, Corrado A, Marchlinski FE et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J. Am. Coll. Cardiol. 55(8), 735–743 (2010).
  • Koichiro K. Catheter ablation of atrial fibrillation – state of the art. Circ. J. 75, 2305–2311 (2011).
  • Santangeli P, Di Biase L, Pelargonio G et al. Catheter ablation of atrial fibrillation: randomized controlled trials and registries, a look back and the view forward. J. Interv. Card. Electrophysiol. 31(1), 69–80 (2011).
  • Di Biase L, Burkhardt JD, Mohanty P et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation 121(23), 2550–2556 (2010).
  • Marchlinski FE, Callans D, Dixit S et al. Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping. J. Cardiovasc. Electrophysiol. 14(4), 358–365 (2003).
  • Arruda M, Mlcochova H, Prasad SK et al. Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. J. Cardiovasc. Electrophysiol. 18(12), 1261–1266 (2007).
  • Corrado A, Bonso A, Madalosso M et al. Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study. J. Cardiovasc. Electrophysiol. 21(1), 1–5 (2010).
  • Miyazaki S, Kuwahara T, Kobori A et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 97(8), 668–673 (2011).
  • Takahashi Y, Sanders P, Rotter M, Haïssaguerre M. Disconnection of the left atrial appendage for elimination of foci maintaining atrial fibrillation. J. Cardiovasc. Electrophysiol. 16(8), 917–919 (2005).
  • Di Biase L, Burkhardt JD, Mohanty P et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 122(2), 109–118 (2010).
  • Kurotobi T, Ito H, Inoue K et al. Marshall vein as arrhythmogenic source in patients with atrial fibrillation: correlation between its anatomy and electrophysiological findings. J. Cardiovasc. Electrophysiol. 17(10), 1062–1067 (2006).
  • Lin WS, Tai CT, Hsieh MH et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 107(25), 3176–3183 (2003).
  • Hsu LF, Jaïs P, Keane D et al. Atrial fibrillation originating from persistent left superior vena cava. Circulation 109(7), 828–832 (2004).
  • Elayi CS, DI Biase L, Bai R et al. Identifying the relationship between the non-PV triggers and the critical CFAE sites post-PVAI to curtail the extent of atrial ablation in longstanding persistent AF. J. Cardiovasc. Electrophysiol. 22(11), 1199–1205 (2011).
  • Fisher JD, Spinelli MA, Mookherjee D, Krumerman AK, Palma EC. Atrial fibrillation ablation: reaching the mainstream. Pacing Clin. Electrophysiol. 29(5), 523–537 (2006).
  • Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol. 16(12), 1286–1292 (2005).
  • Vasamreddy CR, Dalal D, Dong J et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol. 17(2), 134–139 (2006).
  • Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J. Am. Coll. Cardiol. 44(4), 869–877 (2004).
  • Mulder AA, Wijffels MC, Wever EF, Kelder JC, Boersma LV. Arrhythmia detection after atrial fibrillation ablation: value of incremental monitoring time. Pacing Clin. Electrophysiol. 35(2), 164–169 (2012).
  • Verma A, Champagne J, Sapp J et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation pre- and post-radiofrequency ablation (DISCERN AF): a prospective, multicenter study. Presented at: The Heart Rhythm Society 2011 Scientific Sessions. San Francisco, CA, USA, 5 May 2011 (Abstract LB-02).
  • Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J. Cardiovasc. Electrophysiol. 19(7), 762–768 (2008).
  • Reynolds MR, Tara Lavelle T, Essebag V, Cohen DJ, Zimetbaum P. Influence of age, gender, and AF recurrence on quality of life outcomes in a population of new-onset AF patients: the FRACTAL Registry. Am. Heart J. 152(6), 1097–1103 (2006).
  • Ong L, Irvine J, Nolan R et al. Gender differences and quality of life in atrial fibrillation: the mediating role of depression. J. Psychosom. Res. 61(6), 769–774 (2006).
  • Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49(5), 572–577 (2007).
  • Paquette M, Roy D, Talajic M et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am. J. Cardiol. 86(7), 764–768 (2000).
  • Howes CJ, Reid MC, Brandt C et al. Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation. J. Cardiovasc. Pharmacol. Ther. 6(1), 23–29 (2001).
  • Rådholm K, Östgren CJ, Alehagen U et al. Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects. Arch. Gerontol. Geriatr. 52(3), e170–e175 (2011).
  • Weerasooriya R, Jaïs P, Hocini M et al. Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation. Heart Rhythm 2(6), 619–623 (2005).
  • Fichtner S, Deisenhofer I, Kindsmüller S et al. Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 23(2), 121–127 (2012).
  • Goldberg A, Menen M, Mickelsen S et al. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J. Interv. Card. Electrophysiol. 8(1), 59–64 (2003).
  • Peinado R, Arribas F, Ormaetxe JM, Badía X. Variation in quality of life with type of atrial fibrillation. Rev. Esp. Cardiol. 63(12), 1402–1409 (2010).
  • Wokhlu A, Monahan KH, Hodge DO et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J. Am. Coll. Cardiol. 55(21), 2308–2316 (2010).
  • Spertus J, Dorian P, Bubien R et al. Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation. Circ. Arrhythm. Electrophysiol. 4(1), 15–25 (2011).
  • Arribas F, Ormaetxe JM, Peinado R, Perulero N, Ramírez P, Badia X. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace 12(3), 364–370 (2010).
  • Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 132(4), 1259–1264 (2007).
  • Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J. Psychosom. Res. 63(5), 509–513 (2007).
  • Andrade JG, Khairy P, Verma A et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin. Electrophysiol. 35(1), 106–116 (2012).
  • Jahangir A, Lee V, Friedman PA et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 115(24), 3050–3056 (2007).
  • Pappone C, Radinovic A, Manguso F et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm 5(11), 1501–1507 (2008).
  • Pappone C, Vicedomini G, Augello G et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ. Arrhythm. Electrophysiol. 4(6), 808–814 (2011).
  • Daly M, Melton I, Crozier I. Pulmonary vein ablation for atrial fibrillation: the Christchurch, New Zealand experience. J. NZ Med. Assoc. 124, 1343 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.